Castleview Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Castleview Partners's ELV Position: Q3 2026 in Review
Castleview Partners increased its Elevance Health (ELV) stake by 5.7% in Q3 2026, buying an estimated $107K and bringing the position to 4,972 shares worth $1.93M. The position accounts for 0.85% of the portfolio, ranked #25.
Castleview Partners first reported a position in ELV in Q2 2021 and has held it in 14 quarters since. The position peaked at $2.15M in Q3 2025. 236 funds tracked by Wall St. Rank hold ELV as of Q3 2026.
- Castleview Partners held 4,972 shares of Elevance Health worth $1.93M as of Q3 2026.
- Castleview Partners bought 269 Elevance Health shares in Q3 2026, an estimated $107K.
- Elevance Health made up 0.85% of Castleview Partners's portfolio in Q3 2026, its #25 holding.
- Castleview Partners first reported a position in Elevance Health in Q2 2021 and has held it in 14 quarters since.
- Castleview Partners's Elevance Health position peaked at $2.15M in Q3 2025.
- 236 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.
Based on Castleview Partners's 13F filing for Q3 2026, filed 9 Oct 2026.